\-\ Texto\\:\\ \ \(0\)\
\-\ asymptomatic\\.\\ \\ initial\\ labs\\ \\(cbc\\/chem\\)\\ wnl\\.\ \(0\)\
\-\ patient\\ is\\ scheduled\\ for\\ lesion\\ resection\\ in\\ august\\ 2004\\.\ \(0\)\
\-\ pa\\/lat\\ cxr\\:\\ \\ there\\ is\\ irregularity\\ to\\ the\\ contour\\ of\\ the\\ right\\ hilum\\ on\\ the\\ pa\\ view\\.\\ \\ on\\ the\\ lateral\\ view\\,\\ there\\ is\\ a\\ central\\,\\ rml\\ nodule\\ which\\ when\\ going\\ back\\ to\\ the\\ pa\\,\\ can\\ barely\\ be\\ seen\\.\ \(0\)\
\-\ axial\\ ct\\:\\ \\ note\\ the\\ round\\,\\ smooth\\ nodule\\ just\\ anterior\\ to\\ the\\ takeoff\\ of\\ the\\ medial\\ rml\\ bronchus\\.\\ \\ there\\ is\\ no\\ calcification\\,\\ and\\ no\\ strong\\ enhancement\\ with\\ intravenous\\ contrast\\.\\ \\ the\\ lesion\\ does\\ not\\ appear\\ to\\ involve\\ the\\ bronchial\\ lumen\\.\\ \\ \ \(0\)\
\-\ coronal\\ ct\\ reformation\\:\\ \\ round\\ nodule\\ superior\\ to\\ the\\ rml\\ bronchus\\ again\\ demonstrated\\.\ \(0\)\
\-\ typical\\ bronchial\\ carcinoid\ \(0\)\
\-\ hilar\\ lad\ \(0\)\
\-\ primary\\ bronchial\\ neoplasm\ \(0\)\
\-\ primary\\ lung\\ neoplasm\ \(1\)\
\-\ metastatic\\ disease\ \(243\)\
\-\ 66yo\\ asymptomatic\\ female\\ with\\ significant\\ past\\ smoking\\ history\\ and\\ abnormal\\,\\ incidental\\ chest\\ finding\\ on\\ routine\\ ebct\\.\ \(0\)\
\-\ the\\ location\\ of\\ this\\ lesion\\ is\\ somewhat\\ more\\ peripheral\\ than\\ is\\ usually\\ seen\\ with\\ typical\\ carcinoids\\.\\ \\ this\\ carcinoid\\ is\\ also\\ \\"atypical\\"\\ in\\ that\\ it\\ does\\ not\\ enhance\\,\\ and\\ is\\ not\\ calcified\\.\\ \\ the\\ pathology\\,\\ however\\,\\ was\\ consistent\\ with\\ a\\ low\\-grade\\ \\(typical\\)\\ bronchial\\ carcinoid\\.\\ \\ this\\ patient\\ fell\\ into\\ the\\ 25\\%\\ of\\ patients\\ who\\ present\\ asymptomatically\\ with\\ the\\ lesion\\ as\\ an\\ incidental\\ finding\\ on\\ another\\ study\\,\\ which\\ in\\ this\\ case\\ was\\ an\\ ebct\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ bronchial\\:\\ 0\\.30697935140626675\ \(0\)\
\-\ rml\\:\\ 0\\.28740866358551226\ \(0\)\
\-\ carcinoid\\:\\ 0\\.23818882933961227\ \(0\)\
\-\ ebct\\:\\ 0\\.23035485852802942\ \(0\)\
\-\ the\\:\\ 0\\.22558897387017748\ \(0\)\
\-\ nodule\\:\\ 0\\.17847147683943615\ \(0\)\
\-\ typical\\:\\ 0\\.17474679953090555\ \(0\)\
\-\ pa\\:\\ 0\\.17352166642141434\ \(0\)\
\-\ is\\:\\ 0\\.16512709617163804\ \(0\)\
\-\ bronchus\\:\\ 0\\.1593864153622125\ \(0\)\
\-\ lesion\\:\\ 0\\.1445383225719419\ \(0\)\
\-\ round\\:\\ 0\\.12351412477471652\ \(0\)\
\-\ reformation\\:\\ 0\\.12053479265021347\ \(0\)\
\-\ 66yo\\:\\ 0\\.12053479265021347\ \(0\)\
\-\ asymptomatically\\:\\ 0\\.12053479265021347\ \(0\)\
\-\ incidental\\:\\ 0\\.11173919636482248\ \(0\)\
\-\ view\\:\\ 0\\.11038868078992004\ \(0\)\
\-\ carcinoids\\:\\ 0\\.10842794962009426\ \(0\)\
\-\ does\\:\\ 0\\.10421131087153743\ \(0\)\
\-\ this\\:\\ 0\\.10359546518786979\ \(0\)\
\-\ neoplasm\\:\\ 0\\.10290427574657265\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.10262239821807256\ \(0\)\
\-\ takeoff\\:\\ 0\\.10221784624905418\ \(0\)\
\-\ barely\\:\\ 0\\.09926947641951461\ \(0\)\
\-\ finding\\:\\ 0\\.0990849682438671\ \(0\)\
\-\ to\\:\\ 0\\.09421313115793692\ \(0\)\
\-\ primary\\:\\ 0\\.09269018742297896\ \(0\)\
\-\ on\\:\\ 0\\.09105346023249299\ \(0\)\
\-\ there\\:\\ 0\\.0899697769109203\ \(0\)\
\-\ lad\\:\\ 0\\.08946634444583478\ \(0\)\
\-\ not\\:\\ 0\\.08926414877237543\ \(0\)\
\-\ going\\:\\ 0\\.08614575609045788\ \(0\)\
\-\ august\\:\\ 0\\.082344646276077\ \(0\)\
\-\ hilum\\:\\ 0\\.0809525300183553\ \(0\)\
\-\ strong\\:\\ 0\\.0785435364616961\ \(0\)\
\-\ with\\:\\ 0\\.07379301548256956\ \(0\)\
\-\ irregularity\\:\\ 0\\.07300392351200072\ \(0\)\
\-\ seen\\:\\ 0\\.07096820452978407\ \(0\)\
\-\ wnl\\:\\ 0\\.07068574051121358\ \(0\)\
\-\ scheduled\\:\\ 0\\.06994739850392401\ \(0\)\
\-\ smoking\\:\\ 0\\.06980455512492592\ \(0\)\
\-\ hilar\\:\\ 0\\.06911262301385358\ \(0\)\
\-\ intravenous\\:\\ 0\\.06871421442221912\ \(0\)\
\-\ somewhat\\:\\ 0\\.06858403717347866\ \(0\)\
\-\ which\\:\\ 0\\.06854397554645741\ \(0\)\
\-\ contour\\:\\ 0\\.06782880968929858\ \(0\)\
\-\ enhance\\:\\ 0\\.0674667902252325\ \(0\)\
\-\ again\\:\\ 0\\.0672308396003565\ \(0\)\
\-\ lumen\\:\\ 0\\.06711442577355703\ \(0\)\
\-\ fell\\:\\ 0\\.06711442577355703\ \(0\)\
\-\ involve\\:\\ 0\\.06632704231373798\ \(0\)\
\-\ smooth\\:\\ 0\\.062229001264788274\ \(0\)\
\-\ atypical\\:\\ 0\\.06183455752955821\ \(0\)\
\-\ another\\:\\ 0\\.06168001911444474\ \(0\)\
\-\ calcified\\:\\ 0\\.060717310581312044\ \(0\)\
\-\ cxr\\:\\ 0\\.060295586999928034\ \(0\)\
\-\ just\\:\\ 0\\.060295586999928034\ \(0\)\
\-\ coronal\\:\\ 0\\.06002173504436012\ \(0\)\
\-\ appear\\:\\ 0\\.05936095316508774\ \(0\)\
\-\ pathology\\:\\ 0\\.0591689950595188\ \(0\)\
\-\ of\\:\\ 0\\.0589991604017743\ \(0\)\
\-\ routine\\:\\ 0\\.05836796897188102\ \(0\)\
\-\ an\\:\\ 0\\.05764330908555621\ \(0\)\
\-\ ct\\:\\ 0\\.05738896864539239\ \(0\)\
\-\ note\\:\\ 0\\.05673884395811685\ \(0\)\
\-\ in\\:\\ 0\\.056249648592899784\ \(0\)\
\-\ peripheral\\:\\ 0\\.053896602280425816\ \(0\)\
\-\ calcification\\:\\ 0\\.053811631673320044\ \(0\)\
\-\ 25\\:\\ 0\\.05339478688632371\ \(0\)\
\-\ was\\:\\ 0\\.05253514711893063\ \(0\)\
\-\ location\\:\\ 0\\.05248319208760601\ \(0\)\
\-\ labs\\:\\ 0\\.05221778807936729\ \(0\)\
\-\ initial\\:\\ 0\\.05056181415595673\ \(0\)\
\-\ central\\:\\ 0\\.05033201907923239\ \(0\)\
\-\ back\\:\\ 0\\.05026709077231936\ \(0\)\
\-\ study\\:\\ 0\\.05026709077231936\ \(0\)\
\-\ medial\\:\\ 0\\.04906086783889375\ \(0\)\
\-\ past\\:\\ 0\\.04906086783889375\ \(0\)\
\-\ patient\\:\\ 0\\.049028868364901494\ \(0\)\
\-\ no\\:\\ 0\\.049019646320579265\ \(0\)\
\-\ superior\\:\\ 0\\.04900188165222908\ \(0\)\
\-\ resection\\:\\ 0\\.04831385374707647\ \(0\)\
\-\ usually\\:\\ 0\\.04744889819152023\ \(0\)\
\-\ and\\:\\ 0\\.046723543372309835\ \(0\)\
\-\ demonstrated\\:\\ 0\\.04632104842028815\ \(0\)\
\-\ lung\\:\\ 0\\.045849109542858146\ \(0\)\
\-\ when\\:\\ 0\\.045528503910261774\ \(0\)\
\-\ abnormal\\:\\ 0\\.045281945911957916\ \(0\)\
\-\ however\\:\\ 0\\.044610877208280865\ \(0\)\
\-\ axial\\:\\ 0\\.043537056141280894\ \(0\)\
\-\ significant\\:\\ 0\\.0435176111283989\ \(0\)\
\-\ enhancement\\:\\ 0\\.04338229145684636\ \(0\)\
\-\ than\\:\\ 0\\.042725732070457406\ \(0\)\
\-\ who\\:\\ 0\\.04263454548446011\ \(0\)\
\-\ patients\\:\\ 0\\.04240036418015274\ \(0\)\
\-\ anterior\\:\\ 0\\.042082816306906426\ \(0\)\
\-\ more\\:\\ 0\\.04138679382250859\ \(0\)\
\-\ metastatic\\:\\ 0\\.0413372763983994\ \(0\)\
\-\ consistent\\:\\ 0\\.040867939079840127\ \(0\)\
\-\ into\\:\\ 0\\.04006597773232804\ \(0\)\
\-\ chest\\:\\ 0\\.03978468442667939\ \(0\)\
\-\ can\\:\\ 0\\.03955236399992183\ \(0\)\
\-\ present\\:\\ 0\\.038675357922183524\ \(0\)\
\-\ it\\:\\ 0\\.03858141117080007\ \(0\)\
\-\ case\\:\\ 0\\.03786561960749222\ \(0\)\
\-\ lateral\\:\\ 0\\.03740502025802005\ \(0\)\
\-\ contrast\\:\\ 0\\.036621277212569976\ \(0\)\
\-\ female\\:\\ 0\\.036370030709682116\ \(0\)\
\-\ also\\:\\ 0\\.03545240400770121\ \(0\)\
\-\ that\\:\\ 0\\.03270822962194988\ \(0\)\
\-\ disease\\:\\ 0\\.031638108997266975\ \(0\)\
\-\ be\\:\\ 0\\.030575040934160955\ \(0\)\
\-\ as\\:\\ 0\\.030279244666884877\ \(0\)\
\-\ history\\:\\ 0\\.02879612239209202\ \(0\)\
\-\ right\\:\\ 0\\.024988637241583293\ \(0\)\
\-\ for\\:\\ 0\\.022844401091766026\ \(0\)\
